Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prodex: Dexmedetomidine vs Propofol for ICU Sedation
NCT00479661Phase 3Completed
- Sponsor
- Orion Corporation
- Start
- May 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in mechanical ventilation (2 arms), sponsored by Orion Corporation. Primary endpoints: Depth of sedation using the Richmond Agitation-Sedation Scale (RASS) and Duration of mechanical ventilation. Started May 2007; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
mechanical ventilation
Beyond the preview
Go deeper on NCT00479661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00479661.